Research article · 15 Jun 2025
Research articlePublished 10 Oct 2013
An Ex vivo study of Amphotericin-B Nanoparticle for Ocular Delivery
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Our aim was to entrap Amphotericin-B, within the nanoparticles so that it could penetrate the cornea effectively. Solvent displacement method was used to prepare the nanoparticles. Confocal laser scanning microscopy was used to check the corneal penetration of the nanoparticle into isolated goat eyes after contact time of 1 hr and 24 hrs with the formulations. Prepared nanoparticles had particle size range from 112 to 350 nm with a zeta potential of 19 to 34 mV. This positive zeta helps the nanoparticle to adhere with corneal mucosa and release the drug. Almost 60-70% of the drug was released from every formulation in 6 to 7 hrs. The nanoparticles were able to entrap upto 75% of the drug successfully. Ex-vivo study reveals that 50% of the topically applied drug penetrated the cornea within 24 hrs whereas the plain drug solution had negligible penetration capacity.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. EuroSciCon does not store it.
More from this journal
The newest in British Biomedical Bulletin.
Research article · 27 Apr 2025
The Intersection of Cancer Biomarkers and Superficial Acral Fibromyxoma: A Review of Literature for Pathologists and Dermatologists
Review article · 26 Apr 2025
A Detailed Review on Cancers: It's Physical and Biochemical Basis
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalBritish Biomedical Bulletin
- SubjectNanotechnology
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Swarnali Das Paul”
- BylineArticles whose byline prints “Rupa Mazumder”
- BylineArticles whose byline prints “Snehendu Bhattacharya”
- BylineArticles whose byline prints “Arvind Kumar Jha”
